N-benzoylureidocinnamic acid derivatives, processes for...

Details N-benzoylureidocinnamic acid derivatives, processes for... N-benzoylureidocinnamic acid derivatives, processes for...

2006-05-23

2006-05-23

Zucker, Paul A. (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S563000, C514S596000, C560S034000, C562S439000, C564S153000

Reexamination Certificate

active

07049341

ABSTRACT:
N-Benzoylureidocinnamic acid derivatives, processes for preparing them and their useThe invention relates to N-benzoylureidocinnamic acid derivatives and to their physiologically tolerated salts and physiologically functional derivatives. The invention thus relates to compounds of formula I,in which the radicals have the given meanings, and to their physiologically tolerated salts and processes for preparing them. The compounds are, for example, suitable for use as antidiabetic agents.

REFERENCES:
patent: 3435116 (1969-03-01), Weber et al.
patent: 5190923 (1993-03-01), Vincent et al.
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch et al.
patent: 6624185 (2003-09-01), Glombik et al.
patent: 6884812 (2005-04-01), Glombik et al.
patent: 0193249 (1986-09-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
Asakawa, A., et. al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety And Gastric Emptying In Mice, Hormone Metabolis Research, (2001), vol. 33, pp. 554-558.
Drueckes, P., et. al., Photmetric Microtiter Assay Of Inorganic Phosphate In The Presence Of Acid-Labile Organic Phosphates, Analytical Biochemistry, (1995), vol. 230, pp. 173-177.
Engers, H.D., et. al., Kinetic Mechanism Of Phosphorylase a. I. Initial Velocity Studies, Journal Of Biochemistry, (1970), vol. 48, pp. 746-754.
Lee, D.W., et. al., Leptin Agonists As A Potential Approach To The Treatment Of Obesity, Drugs Of The Future, (2001), vol. 26, No. 9, pp. 873-881.
Okada, H., et al., Synthesis And Antitumor Of Prodrugs Of Benzoylphenylureas, Chemical And Pharmaceutical Bulletin, (1994), vol. 42, No. 1, pp. 57-61.
Salvador, J., et. al., Perspectives In The Therapeutic Use Of Leptin, Expert Opinion, (2001), vol. 2, No. 10, pp. 1615-1622.
Tyle, P., et. al., Iontophoretic Devices For Drug Delivery, Pharmaceutical Research, (1986), vol. 3, No. 6, pp. 318-326.
Zunfit, H.J.F., et. al., Carob Pulp Preparation For Treatment Of Hypercholesterolemia, Advances In Therapy, (2001), vol. 18, No. 5, pp. 230-236.

Affiliated with

Also associated with

Rating

N-benzoylureidocinnamic acid derivatives, processes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-benzoylureidocinnamic acid derivatives, processes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-benzoylureidocinnamic acid derivatives, processes for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3526372